摘要:
Disclosed is a method for supplying hydroxyl radical-containing water, which is highly convenient and with which water containing a relatively high concentration of hydroxyl radicals can be supplied to the point of use. The method for supplying hydroxyl radical-containing water comprises a production step of producing hydroxyl radical-containing water by dissolving ozone, hydrogen peroxide, and at least one additive substance selected from a group consisting of a water-soluble organic compound, an inorganic acid, a salt of an inorganic acid, and hydrazine in pure water, a transferring step of transferring the produced hydroxyl radical-containing water to the point of use, and a supplying step of supplying the hydroxyl radical-containing water to the point of use after transferring.
摘要:
A stable liquid medical formulation containing an antibody is provided, which contains a therapeutically effective amount of an antibody in a glutamate buffer and/or a citrate buffer and has a pH between 4.0 and 6.0.
摘要:
Disclosed is a method for supplying hydroxyl radical-containing water, which is highly convenient and with which water containing a relatively high concentration of hydroxyl radicals can be supplied to the point of use. The method for supplying hydroxyl radical-containing water comprises a production step of producing hydroxyl radical-containing water by dissolving ozone, hydrogen peroxide, and at least one additive substance selected from a group consisting of a water-soluble organic compound, an inorganic acid, a salt of an inorganic acid, and hydrazine in pure water, a transferring step of transferring the produced hydroxyl radical-containing water to the point of use, and a supplying step of supplying the hydroxyl radical-containing water to the point of use after transferring.
摘要:
The present invention relates to novel isoxazole and thiazole compounds having an excellent lysophosphatidic acid (LPA) receptor antagonistic activity represented by general formula [1] or salts thereof: wherein R1 and R2 represents an optionally substituted alkyl group or the like; R3 represents a hydrogen atom or the like; R4 represent a group selected from the group consisting of (I) optionally substituted phenyl, aryl, or heterocycle, (II) substituted or nonsubstituted alkyl, and (III) substituted or nonsubstituted alkenyl, alternatively, R3 and R4 may form a ring structure together with a carbon atom to which they bind; and X represents an oxygen atom or a sulfur atom, provided that, when R3 is a hydrogen atom, R4 represents a group other than methyl, and the use thereof as a medicine.
摘要翻译:本发明涉及具有由通式[1]表示的极好的溶血磷脂酸(LPA)受体拮抗作用或其盐的异恶唑和噻唑化合物,其中R1和R2表示任选取代的烷基等; R3表示氢原子等; R 4表示选自(I)任选取代的苯基,芳基或杂环,(II)取代或未取代的烷基和(III)取代或未取代的烯基的基团,或者,R3和R4可以一起形成环结构 与它们结合的碳原子; 并且X表示氧原子或硫原子,条件是当R 3为氢原子时,R 4表示甲基以外的基团,以及作为药物的用途。
摘要:
A toothed belt having a body with a length, an inside surface, an outside surface, laterally spaced sides, and a plurality of teeth spaced in a lengthwise direction on the inside of the body. An elongate, load carrying cord extends lengthwise of the body and is embedded in the body. A cloth layer is provided on the inside surface of the body. The load carrying cord has a diameter that is greater than 1.1 mm and not greater than 1.5 mm and is prepared by a) bundling glass fiber filaments each having a diameter of from 5 to 10 &mgr;m into strands, b) gathering and primary twisting a plurality of stands in one twist direction to form strings, and c) gathering and final twisting the strings in a direction oppositely to the one twist direction.
摘要:
A power transmission belt having a body defined by rubber and having an exposed outer surface, a fiber layer on at least a part of the exposed outer surface of the body, and a mixture including a resin adhesive ingredient, a rubber ingredient, and a lubricant that is a fluorine resin powder that is applied to the fiber layer.